HAL (France)
open access
APG101 efficiently rescues erythropoiesis in lower risk myelodysplastic syndromes with severe impairment of hematopoiesis.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Telomere and telomerase in hematological disorders Focusing on bone marrow failure syndromes and hematological malignancies#930385
- An Efficacy Study for Epoetin Alfa in Anemic Patients With Myelodysplastic Syndromes#873777
- Loss of hematopoietic progenitors heterogeneity is an adverse prognostic factor in lower-risk myelodysplastic neoplasms#15526
- Ex-Vivo Depletion of Myeloma Cells From Peripheral Blood Progenitor Cell Grafts#852688
- VMAC+DLI Treatment of Patients With Relapse of AML After Allo-HSCT#1058850
Record · ID 1251504
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive